Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong
· Delayed Price · Currency is HKD 414.60
+34.60 (9.11%)
Last updated: Mar 10, 2026, 10:16 AM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 88.61 billion as of March 9, 2026. Its market cap has increased by 113.64% in one year.
Market Cap
88.61B
Enterprise Value
83.81B
Revenue
1.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
414.60
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 88.61B, an increase of 556.90%. That is a compound annual growth rate of 102.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 88.61B | -3.11% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akeso | 98.84B |
| Sino Biopharmaceutical | 109.58B |
| RemeGen | 59.85B |
| Innovent Biologics | 144.54B |
| 3SBio | 53.95B |
| WuXi Biologics | 150.36B |
| Shanghai Henlius Biotech | 37.50B |
| TransThera Sciences (Nanjing) | 36.71B |